Davelaar, John
Jessurun, Naomi
Schaap, Gerko
Bode, Christina
Vonkeman, Harald
Article History
Received: 31 January 2023
Accepted: 23 July 2023
First Online: 8 August 2023
Change Date: 30 October 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10238-023-01217-8
Declarations
:
: Harald Vonkeman has received honorariums from UCB, Novartis, Boehringer, Galapagos and Pfizer. Harald Vonkeman is a board member of the Dutch Arthritis Society. Naomi Jessurun is a board member of the Dutch Royal Society of Pharmacists. All other authors confirm that they have no competing interests to declare.
: Patients provided informed consent for the use of their data from the post COVID database. The institutional review board of MST approved of the use of the patient's data, as collected in the clinical database for COVID-19 related data (K20-K30).